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ABSTRACT Numerous species of bacteria use an elegant
regulatory mechanism known as quorum sensing to control
the expression of specific genes in a cell-density dependent
manner. In Gram-negative bacteria, quorum sensing systems
function through a cell-to-cell signal molecule (autoinducer)
that consists of a homoserine lactone with a fatty acid side
chain. Such is the case in the opportunistic human pathogen
Pseudomonas aeruginosa, which contains two quorum sensing
systems (las and rhl) that operate via the autoinducers,
N-(3-oxododecanoyl)-L-homoserine lactone and N-butyryl-L-
homoserine lactone. The study of these signal molecules has
shown that they bind to and activate transcriptional activator
proteins that specifically induce numerous P. aeruginosa
virulence genes. We report here that P. aeruginosa produces
another signal molecule, 2-heptyl-3-hydroxy-4-quinolone,
which has been designated as the Pseudomonas quinolone
signal. It was found that this unique cell-to-cell signal con-
trolled the expression of lasB, which encodes for the major
virulence factor, LasB elastase. We also show that the syn-
thesis and bioactivity of Pseudomonas quinolone signal were
mediated by the P. aeruginosa las and rhl quorum sensing
systems, respectively. The demonstration that 2-heptyl-3-
hydroxy-4-quinolone can function as an intercellular signal
sheds light on the role of secondary metabolites and shows
that P. aeruginosa cell-to-cell signaling is not restricted to
acyl-homoserine lactones.
Bacteria must constantly monitor the environment in which
they live for changes that require an adaptive response. In the
case of cell density, many species are able to react to the
achievement of a critical density through a cell-to-cell signaling
mechanism known as quorum sensing. In Gram-negative
bacteria, quorum sensing systems consist of an acylated ho-
moserine lactone signal molecule (referred to as an autoin-
ducer) and an autoinducer-dependent transcriptional activator
protein (referred to as an ‘‘R protein’’) (reviewed in ref. 1).
Bacteria at a low cell density produce a basal level of autoin-
ducer, and, as a population grows, autoinducer concentration
increases concomitantly with cell density. On reaching a
threshold concentration, autoinducer binds to and thereby
activates an R protein, which then induces or ceases to repress
specific target genes. In this manner, intercellular signals
enable a bacterial population to control the expression of
specific genes in response to cell density. Such is the case with
the ubiquitous environmental microbe Pseudomonas aerugi-
nosa. This opportunistic pathogen has at least two homologous
quorum sensing systems, the las and rhl systems, which control
a battery of virulence genes (reviewed in ref. 2). The P.
aeruginosa quorum sensing systems have been shown to func-
tion through two autoinducers, N-(3-oxododecanoyl)-L-
homoserine lactone (3-oxo-C12-HSL) (Fig. 1 A), and N-
butyryl-L-homoserine lactone (C4-HSL) (Fig. 1B) (3, 4). In the
las system, LasI catalyzes the synthesis of the 3-oxo-C12-HSL
signal molecule, which binds to and activates the transcrip-
tional activator protein LasR (5, 6). Similarly, in the rhl system,
RhlI catalyzes the synthesis of the C4-HSL signal molecule,
which binds to and activates the transcriptional activator
protein RhlR (7, 8).
Quorum sensing in P. aeruginosa first was discovered be-
cause of the ability of 3-oxo-C12-HSL and LasR to induce the
expression of the lasB gene, which encodes for the elastin-
hydrolyzing protease, LasB (3, 5, 6, 9). Subsequently, the
expression of lasB also was shown to be controlled by C4-HSL
and RhlR, indicating that both known P. aeruginosa cell-to-cell
signals were involved in the regulation of this major virulence
factor (4, 10–12). During our analysis of C4-HSL production,
it was found that P. aeruginosa was capable of producing a third
unknown signal that activated lasB. This observation led to the
discovery and identification of a P. aeruginosa cell-to-cell
signal molecule. This molecule belongs to the 4-quinolone
chemical family, which is best known for the antibiotic activity
of many of its members. We proved that this signal was
2-heptyl-3-hydroxy-4-quinolone and have designated it as the
Pseudomonas quinolone signal (PQS). We also showed that
this compound induced lasB in P. aeruginosa and depended on
the P. aeruginosa quorum sensing systems for its production
and bioactivity.
MATERIALS AND METHODS
Strains, Plasmids, and Reagents. The following bacterial
strains were used in this study: Escherichia coli strain DH5a
(13); the wild-type P. aeruginosa strain PAO1 (14); and the
PAO1 mutant strains PAO-JP2 (lasI, rhlI) (12), PAO-JP3
(lasR, rhlR) (12), and PAO-R1 (lasR) (6). Unless otherwise
indicated, bacterial cultures were grown in peptone trypticase
soy broth (15) supplemented with 200 mgyml carbenicillin
where appropriate. Plasmid pECP39, which encodes a trun-
cated form of LasR (DLasR) that is capable of activating
LasR-controlled genes in the absence of an autoinducer, was
constructed as follows. First, the intermediate plasmid
pKDT39 was constructed by ligating the lasR DNA that
encodes LasR amino acids 160–239 in-frame to the histidine
fusion site of the expression vector pTRCHisC (Invitrogen).
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This resulted in the trcp-DlasR fusion, which encodes for a
truncated, autoinducer-independent form of LasR, the expres-
sion of which is controlled by the trc promoter. The trcp-DlasR-
containing DNA fragment from pKDT39 then was ligated into
the P. aeruginosa cloning vector pUCP22 (16) to form pECP39
(bla, lacIq, trcp-DlasR, oriP, oriC). Plasmid pTS400 (5) contains
a lasB9-lacZ translational fusion, and plasmid pECP62.5 (12)
contains tacp-rhlR and a lasB9-lacZ translational fusion. Trans-
formations and other molecular techniques were completed
with standard procedures (17). The PQS analog 2-hydroxy-3-
heptyl-4-quinolone (Fig. 1D) was synthesized as described
(18), and 2-heptyl-4-hydroxy-quinoline-N-oxide (Fig. 1E) was
purchased from Sigma.
The PQS Bioassay. To monitor PQS bioactivity, 1-ml cul-
tures of P. aeruginosa strain PAO-R1 (pTS400) were grown for
18 h at 37°C with shaking (260 rpm; initial optical density was
0.02 at 660 nm) in the presence of culture extract or synthetic
PQS. This was followed by measuring activation of the lasB9-
lacZ fusion with the use of b-galactosidase (b-gal) assays as
described by Miller (19). For culture extracts, bacterial culture
fluid was extracted with ethyl acetate and was prepared as
described (3). Extracts that were resuspended in ethyl acetate
were added to bioassay tubes, and ethyl acetate was removed
by drying under a stream of nitrogen. Unless otherwise
specified, the amount of material assayed was extracted from
10 ml of culture fluid.
Thin Layer Chromatography (TLC) and High Performance
Liquid Chromatography (HPLC). Preparative TLC plates
were obtained by making 1-mm layers of a slurry of 55-g silica
gel G (Machery & Nagel) in a solution of 5 g of KH2PO4 in 95
ml of water on 20- 3 20-cm glass plates. Plates then were
air-dried and activated at 100°C for 1 h. The solvent for TLC
was a 17:2:1 mixture of dichloromethane-acetonitrile-dioxane
(volyvol). HPLC was performed on a Beckman–Altex Ultra-
sphere 10-mm 3 25-cm C18 reverse phase column. Extracts
were resuspended in 0.25 ml of methanol and were loaded onto
the column that then was eluted (2 mlymin) with an acetoni-
trileywater gradient (10 - 100% over 120 min). Fractions were
collected at the indicated intervals and were dried by rotary
evaporation at room temperature. Evaporated samples were
stored at 220°C before being dissolved in methanol and were
assayed for PQS activity.
Purification of PQS. PQS was purified from 1.2 liters of P.
aeruginosa strain PAO-JP2 (pECP39) that was grown for 24 h
at 37°C with shaking (260 rpm; initial optical density was 0.05
at 660 nm). Cultures were centrifuged for 10 min at 10,000 3
g, and spent supernatant was removed and extracted twice with
ethyl acetate as described (3). The ethyl acetate extract was
dried with sodium sulfate and was concentrated by rotary
evaporation at room temperature. The concentrated material
then was extracted and concentrated three times with progres-
sively smaller volumes of a 1:1 mixture of ethyl acetate and
acetonitrile (final volume, 0.75 ml). This concentrated extract
was fractionated by using Short Body C18 Sep-Pak Plus
cartridges (Waters). After loading the extract onto a cartridge
(0.25 ml per cartridge), it was washed with 10, 30, and 40%
acetonitrile in water (3 ml per cartridge). The active material
then was eluted with 55% acetonitrile in water. This partially
purified extract was dissolved in 0.3 ml of 90% dioxane in water
and was further purified by preparative TLC. After loading the
extract, the TLC plate was eluted twice with 17:2:1 dichlo-
romethaneyacetonitrileydioxane. A fluorescent blue band ex-
tending from Rf 0.30–0.48 was removed and eluted with 1:1
acetonitrileyethyl acetate (3 3 3 ml). The eluate, which
contained 2-heptyl-3-hydroxy-4-quinolone (Fig. 1C), was con-
centrated and analyzed as described below.
Chemical Analysis of Natural and Synthetic PQS. 1H and
13C NMR spectra in DMSO-d6 were recorded on a Bruker
(Bellerica, MA) AM400 NMR spectrometer operating at 400
MHz for 1H or 100.5 MHz for 13C. The chemical shifts are
reported in d (ppm) relative to residual DMSO-d5 (2.49 ppm)
for 1H or relative to DMSO-d6 (39.43 ppm) for 13C, and
coupling constants are given in hertz. Infrared (IR) spectra
were recorded on a Perkin–Elmer 1600 series Fourier Trans-
formed-IR. Melting points were recorded on a Mel-Temp
melting point apparatus and are uncorrected. The ultraviolet
spectra were recorded on a Shimadzu UV-1601 PC spectro-
photometer. Low-resolution MS were recorded on a Hewlett–
Packard 5973 mass selective detector fitted with an SIS direct
insertion probe, and high-resolution electron impact spectra
were recorded at the University of California-Riverside Mass
Spectrometry Facility.
Synthesis of PQS. A mixture of 2-heptylquinolone (2.00 g,
8.22 mmol), hexamine (0.58 g, 4.11 mmol), and trif luoroacetic
acid (12.3 ml) was stirred at reflux under argon for 27 h.
Methanol (20 ml) and water (20 ml) were added, and heating
was continued for 50 min. Hydrochloric acid (2.5 M, 10 ml) was
added, and heating was continued for 30 min. The mixture was
allowed to cool, and the precipitate was removed by filtration
and was washed with water. The solid was triturated with
acetone (10 ml) and then was removed by filtration to give
3-formyl-2-heptylquinolone (0.99 g, 44%), which crystallized
from methanolyethyl acetate as colorless needles: mp 244–
247°C (dec) (Found: C, 75.55; H, 7.95; N, 5.09%. C17H21NO2
requires C, 75.24; H, 7.80; N, 5.16%). 1H NMR 12.11 (br s, 1H),
10.37 (s, 1H), 8.12 (d, J 8.0, 1H), 7.70 (dd, J 8.2, 7.1, 1H), 7.57
(d, J 8.2, 1H), 7.38 (dd, J 8.0, 7.1, 1H), 3.01 (t, J 7.7, 2H), 1.56
(quin., J 7.4, 2H), 1.39–1.16 (m, 8H), 0.82 (t, J 6.4, 3H). 13C
NMR 190.7 (d), 178.0 (s), 159.9 (s), 139.1 (s), 132.9 (d), 126.1
(s), 124.8 (d), 124.9 (d), 118.6 (d), 113.3 (s), 31.5 (t), 31.1 (t),
28.9 (t), 28.8 (t), 28.3 (t), 22.0 (t), 13.8 (q). myz 271 (5%), 253
(8%), 242 (5%), 228 (3%), 214 (8%), 200 (13%), 187 (20%),
172 (16%), 159 (100%), 130 (8%).
Aqueous hydrogen peroxide (1.05 M, 1.49 ml, 1.56 mmol)
was added to a solution of 3-formyl-2-heptylquinolone (0.41 g,
1.49 mmol) in ethanol (4.5 ml) and aqueous sodium hydroxide
(1.08 M, 1.49 ml, 1.6 mmol) under argon, and the mixture was
stirred at room temperature for 6 h. The precipitate was
removed by filtration, was air dried, and was crystallized from
ethyl acetate to give 2-heptyl-3-hydroxy-4-quinolone (0.29 g,
FIG. 1. Chemical structures of relevant compounds. (A) 3-oxo-
C12-HSL. (B) C4-HSL. (C) 2-heptyl-3-hydroxy-4-quinolone (PQS).
(D) 2-hydroxy-3-heptyl-4-quinolone. (E) 2-heptyl-4-hydroxy-
quinoline-N-oxide.
11230 Biochemistry: Pesci et al. Proc. Natl. Acad. Sci. USA 96 (1999)
74%), as off-white needles: mp 196–198°C (dec) (Found: C,
74.30; H, 8.42; N, 5.21%. C16H21NO2 requires C, 74.10; H, 8.16;
N, 5.40%). lmax (log «) methanol 217 (4.43), 250 (4.56), 292
(3.34), 343 (4.08), 351 nm (4.08). nmax (KBr) 3,275, 2,929, 1,639,
1,599, 1,558, 1,488, 1,467, 1,416, 1,367, 1,265, 1,115, 1,073,
1,025, 954, 934, 863, 756, 710, 895, 574 cm21. 13C NMR 168.8
(s), 137.7 (s), 137.3 (s), 135.4 (s), 129.8 (d), 124.4 (d), 122.1 (s),
121.4 (d), 117.7 (d), 31.1 (t), 28.7 (t), 28.4 (t), 28.0 (t), 27.7 (t),
21.9 (t), 13.8 (q). 1H NMR and MS of synthetic PQS are
presented in Results.
RESULTS
Discovery of a Novel Cell-to-Cell Signal. The LasB elastase
is a significant P. aeruginosa virulence factor that is controlled
by both the las and rhl quorum sensing systems (6, 8). It has
been shown that the transcription of lasB is greatly reduced in
either a P. aeruginosa lasI or rhlI mutant, indicating the
importance of 3-oxo-C12-HSL and C4-HSL, respectively (11,
12). Consistent with this finding, strain PAO-R1 (pTS400),
which contains a LasR null mutation and a lasB9-lacZ fusion,
does not express elastase or b-gal (6, 7). This phenotype results
from the absence of LasR, which positively regulates genes
controlled by the las quorum sensing system including rhlR,
which is required for the rhl quorum sensing system to function
(8, 20, 21). As one would expect, the absence of lasR also
renders the lasB9-lacZ fusion in strain PAO-R1 (lasR2)
(pTS400) unresponsive to 3-oxo-C12-HSL (4). Additionally,
lasB9-lacZ in this strain is mildly activated by exogenously
added C4-HSL, which is probably attributable to the presence
of low amounts of RhlR that can be produced in the absence
of LasR (4, 20). Therefore, we were surprised to find that the
addition of a spent culture media extract from P. aeruginosa
strain PAO1 (wild type) to strain PAO-R1 (lasR2) (pTS400)
caused a major induction of lasB9-lacZ (Fig. 2A). This induc-
tion could not be mimicked with the addition of synthetic
3-oxo-C12-HSL andyor C4-HSL (data not shown), indicating
that an unknown third signal was present in the media from the
wild-type strain PAO1. HPLC separation of a strain PAO1
spent media extract resulted in two fractions that activated the
lasB promoter in strain PAO-R1 (lasR2) (pTS400) (data not
shown). One fraction co-eluted with C4-HSL, and the other
eluted near 3-oxo-C12-HSL. We presumed the material that
eluted near 3-oxo-C12-HSL was a novel cell-to-cell signal.
The lack of lasB9-lacZ induction in strain PAO-R1 (lasR2)
(pTS400) without the addition of extract (5) showed that
production of the novel signal required LasR and presumably
3-oxo-C12-HSL. Thus, HPLC purification of the novel signal
from wild-type strain PAO1 was hampered by the fact that it
was not readily separated from 3-oxo-C12-HSL, which is re-
quired for LasR activity. This presented a technical difficulty
that was overcome by construction of a gene that encoded an
autoinducer-independent form of LasR. This truncated LasR,
referred to as DLasR, has a large N-terminal deletion and is
encoded on plasmid pECP39. The DLasR protein, which was
based on a similar truncated construct of the Vibrio fischeri
LuxR protein (a LasR homolog) (22), can activate LasR-
controlled genes in the absence of 3-oxo-C12-HSL (data not
shown). Therefore, DLasR was used to induce the production
of the novel signal in strain PAO-JP2 (lasI2, rhlI2). The double
autoinducer mutant, strain PAO-JP2, was transformed with
plasmid pECP39, and it was found that a spent culture media
extract from this strain contained the novel signal that acti-
vated lasB9-lacZ in strain PAO-R1 (lasR2) (pTS400) (Fig. 2 A).
There were no lasB9-lacZ activating signals in spent media
extracts from cultures of strain PAO-JP2 (lasI2, rhlI2) alone or
containing the control vector pUCP22 (Fig. 2 A). This con-
firmed that the synthesis of the new signal depended on LasR
and indicated that the signal was not produced by a known
autoinducer synthase because strain PAO-JP2 does not have a
functional LasI or RhlI.
An initial analysis of the novel signal activity showed that,
when the lasR, rhlR double mutant, strain PAO-JP3, contain-
ing pTS400 replaced strain PAO-R1(lasR2) (pTS400) in our
bioassay, the signal in culture extracts of strains PAO1 and
PAO-JP2 (lasI2, rhlI2) (pECP39) was no longer able to induce
lasB9-lacZ (Fig. 2B). This suggested that rhlR was required for
the bioactivity of the new signal. With this information, we
attempted to define the requirements for signal activity by
developing an E. coli bioassay for the signal. E. coli strain
DH5a was transformed with plasmid pECP62.5, which con-
tains the lasB9-lacZ reporter and the inducible tacp-rhlR gene.
If the signal worked directly through RhlR, then the induction
of tacp-rhlR in the presence of exogenously added signal should
result in the activation of lasB9-lacZ in E. coli strain DH5a
(pECP62.5). We found that the signal did not induce lasB9-
lacZ when RhlR was expressed in E. coli strain DH5a
(pECP62.5) (data not shown). This suggested that the signal’s
requirement for rhlR may be attributable to an additional P.
aeruginosa component that is controlled by RhlR or, alterna-
tively, that E. coli may be less permeable to this signal.
Purification and Identification of the Novel Cell-to-Cell
Signal. HPLC analysis of a spent media extract from a culture
of strain PAO-JP2 (lasI2, rhlI2) (pECP39) showed that a single
peak of bioactivity was eluted from an acetonitrileywater
gradient (Fig. 3). This indicated that, if multiple signals capable
of activating lasB9-lacZ were produced, they would be similar
with regard to their hydrophobicity. The eluted signal was
further purified by preparative TLC (see Materials and Meth-
ods) and was chemically analyzed to determine its structure.
Chemical analysis of the purified signal indicated that,
unlike most other Gram-negative autoinducers, it was not an
acylated homoserine lactone. Low-resolution mass spectros-
copy analysis showed a molecular ion of myz 259 and a
fragmentation pattern consistent with an alkylquinolone that
had an additional oxygenation on the heteroaromatic core
(Fig. 4A). The ultraviolet spectrum (data not shown) and
downfield signals of the 1H NMR (Fig. 5A) were similar to
those of the known 3-hydroxy-2-methyl-4-quinolone (23, 24).
However, the molecular ion and upfield signals of the 1H NMR
(Fig. 5A) suggested the presence of a heptyl rather than a
methyl chain in position 2. High-resolution mass spectroscopy
FIG. 2. A novel signal induces lasB in P. aeruginosa. Strain
PAO-R1 (lasR2) (pTS400) (A) or strain PAO-JP3 (lasR2, rhlR2)
(pTS400) (B) was grown in the presence of culture supernatant extracts
from the following P. aeruginosa strains: PAO1 (wild type), PAO-JP2
(lasI2, rhlI2), PAO-JP2 (pECP39), or PAO-JP2 (pUCP22). After 18 h
of growth, b-gal activity was assayed and is presented in Miller units
1y2 SDn21. (Note: A control culture with no extract added produced
8 Miller units of b-gal activity.) Data represent the means of duplicate
assays performed during three separate experiments.
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gave a molecular ion with an myz of 259.1571, consistent with
the chemical composition C16H21NO2 (calculated 5 259.1572).
Taken together, these data indicated that the novel signal was
2-heptyl-3-hydroxy-4-quinolone (Fig. 1C), which we have des-
ignated as the Pseudomonas quinolone signal (PQS).
Analysis of Synthetic PQS. To confirm our identification of
PQS, we prepared synthetic 2-heptyl-3-hydroxy-4-quinolone
by sequential Duff reaction (25) and Dakin oxidation (26) of
2-heptylquinolone (27) (see Materials and Methods). The low-
resolution mass spectrum (Fig. 4B), high-resolution mass
spectrum (myz of 259.1578), and 1H NMR spectrum (Fig. 5B)
of synthetic 2-heptyl-3-hydroxy-4-quinolone were indistin-
guishable from those of purified natural PQS. Synthetic and
natural PQS were also identical with regard to ultraviolet
spectroscopy and TLC analysis (data not shown). Further-
more, the synthetic material was active in the PQS bioassay. In
the presence of increasing concentrations of synthetic or
natural PQS, there was a dose-dependent induction of lasB9-
lacZ in strain PAO-R1 (lasR2) (pTS400) (Fig. 6).
The purification of PQS from a 1.2-liter culture of strain
PAO-JP2 (lasI2, rhlI2) (pECP39) yielded an average of 1.8 mg
of PQS, which is equivalent to a concentration of ’6 mM in the
culture fluid. This concentration, which is likely to be an
underestimate of the actual amount in culture fluid (assuming
the total recovery in the purification was ,100%), was within
the range required for activation of the lasB promoter in P.
aeruginosa strain PAO-R1(lasR2) (pTS400) (Fig. 6; 5 mM
FIG. 3. HPLC analysis of a novel signal extracted from P.
aeruginosa culture medium. A culture medium extract from strain
PAO-JP2 (lasI2, rhlI2) (pECP39) was separated by reverse-phase
HPLC, and fractions were collected between the times indicated by
each point on the graph. The extract was loaded onto the column at
time 0. Fractions were assayed for our bioactive signal, and results are
presented as b-gal activity in Miller units. These data are the average
of duplicate b-gal assays from one experiment that was representative
of multiple repeated experiments. The dashed line (----) indicates
acetonitrile concentration.
FIG. 4. Electron impact mass spectra of purified natural PQS (A)
and synthetic PQS (B). Natural PQS was purified from strain PAO-JP2
(lasI2, rhlI2) (pECP39). Comparable peaks are labeled with their
respective myz.
FIG. 5. 1H NMR spectra of purified, natural PQS (A) and synthetic
PQS (B) in DMSO-d6. 1H NMR spectra for natural and synthetic PQS
are identical and can be described as follows: 11.42 (br s, 1H), 8.08 (d,
J 8.0, 1H), 8.05 (br s, 1H), 7.55–7.48 (m, 2H), 7.23–7.17 (m, 1H), 2.72
(t, J 7.5, 2H), 1.65 (quin., J 6.4, 2H), 1.35–1.18 (m, 8H), 0.82 (t, J 6.7,
3H).
FIG. 6. PQS bioassay with synthetic or natural PQS. Synthetic PQS
(open squares), natural PQS (closed squares), 2-hydroxy-3-heptyl-4-
quinolone (circles), or 2-heptyl-4-hydroxy-quinoline-N-oxide (trian-
gles) were added to bioassay cultures at the indicated concentrations.
Data represent the means of duplicate assays performed during three
separate experiments and are presented as b-gal activity in Miller units
1y2 SDn21.
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synthetic PQS 5 148 Miller units). It is also interesting to note
here that two PQS analogs were not capable of activating
lasB9-lacZ in strain PAO-R1 (lasR2) (pTS400). Despite their
structural similarities to PQS, the compounds 2-hydroxy-3-
heptyl-4-quinolone (Fig. 1D) and 2-heptyl-4-hydroxy-
quinoline-N-oxide (Fig. 1E) were not active when tested in our
PQS bioassay (Fig. 6). These results suggested that the PQS
target may be specific with regard to the compounds by which
it is activated.
DISCUSSION
We have discovered that P. aeruginosa produces a cell-to-cell
signal that is unlike any previously reported intercellular signal
molecule. This molecule was determined to have a 4-quinolone
base structure and therefore has been designated as the Pseudo-
monas quinolone signal (PQS). Our results showed that exog-
enously added PQS induced a lasB9-lacZ fusion in the P. aerugi-
nosa lasR mutant, strain PAO-R1, containing the plasmid pTS400
(Fig. 2A). This indicates that there is a third cell-to-cell signal, in
addition to the autoinducers 3-oxo-C12-HSL and C4-HSL, that is
involved in lasB induction by P. aeruginosa. Despite the ability of
PQS to activate lasB9-lacZ in the absence of lasR, the production
of PQS required an active LasR protein (Fig. 2A). This suggested
that a gene (or genes) required for PQS synthesis is controlled
through the las quorum sensing system. We also found that at
least RhlR was required for PQS to act as a signal because
lasB9-lacZ was not induced by PQS in the lasR, rhlR double
mutant, strain PAO-JP3, containing the plasmid pTS400 (Fig.
2B). Although the basis of the requirement for rhlR is not known,
we suggest that RhlR may serve to regulate the expression of a
P. aeruginosa gene that is involved in the response to PQS. This
idea stems from our inability to replicate the PQS response by
adding PQS to a recombinant E. coli strain expressing RhlR in the
presence of lasB9-lacZ (data not shown). These initial experi-
ments on PQS indicated that this signal depended on both P.
aeruginosa quorum sensing systems and that it was involved in the
regulation of the major virulence factor, LasB elastase.
The addition of a third molecule to the P. aeruginosa
intercellular signal repertoire increases the complexity of the
quorum sensing hierarchy. With regard to the relationship of
these cell-to-cell signals, our data imply that 3-oxo-C12-HSL is
required for the production of PQS, and previous results
suggested that 3-oxo-C12-HSL also positively regulates the
production of C4-HSL (20, 21). These findings mean that
3-oxo-C12-HSL can be considered the dominant P. aeruginosa
cell-to-cell signal that is responsible, with LasR, for initiating
the start of the quorum sensing response. The relationship
between PQS and C4-HSL is difficult to determine from our
data. To act as signals, both molecules require RhlR. The
C4-HSL signal has been shown to interact with RhlR (12), but
it is not clear whether PQS acts directly or indirectly through
RhlR. In either case, it is possible that PQS and C4-HSL
produce an additive effect on the induction of lasB. Deter-
mining the relative position of PQS within the P. aeruginosa
quorum sensing hierarchy will provide an interesting insight as
to its role in the regulation of specific genes.
To facilitate the purification of PQS, we constructed a
mutated lasR gene that encoded a truncated protein (DLasR)
capable of activating LasR-controlled genes in the absence of
3-oxo-C12-HSL. PQS was purified by sequential reverse phase
column chromatography and TLC from the double autoin-
ducer mutant, strain PAO-JP2, that was expressing the DLasR
protein. Based primarily on the spectral properties of the
purified material (Figs. 4 and 5), we concluded that the novel
signal molecule was 2-heptyl-3-hydroxy-4-quinolone (Fig. 1C).
This compound was synthesized, and all chemical analysis
(including high and low resolution MS, 1H NMR spectra, UV
spectra, and TLC) showed that synthetic 2-heptyl-3-hydroxy-
4-quinolone was identical to natural PQS.
As a confirmation of the structural assignment, we showed
that synthetic PQS, but not other similar quinolones, had
biological activity (Fig. 6). Based on the activity profile of
synthetic PQS and the amount of signal we purified from P.
aeruginosa culture fluid, we conservatively estimated that the
concentration of PQS in culture fluid was ’6 mM, which is in
the active concentration range (Fig. 6). This concentration is
similar to the approximate concentrations of 3-oxo-C12-HSL (1
to 5 mM; refs. 3 and 4) and C4-HSL (10 mM; ref. 4) found in
culture supernatants. The amount of PQS required to activate
our bioassay to half of its maximum activity was ’30 mM (Fig.
6). Similar P. aeruginosa bioassays for 3-oxo-C12-HSL and
C4-HSL showed that a concentration of ’1 mM was required
for these signals to activate their respective assays to half of
their maximum activity (4). These differences suggest that,
with regard to lasB9-lacZ induction, the relative potency of
PQS may not be as high as the potencies of 3-oxo-C12-HSL and
C4-HSL. However, we do not yet fully understand the biolog-
ical significance of this 4-quinolone signal in P. aeruginosa. The
conditions under which PQS may be involved in lasB induction
and whether lasB or another gene is the primary target of PQS
are some of the questions that remain to be answered.
It has been well established that 4-quinolones are secondary
metabolites that can have potent antibiotic activity (28). It is
now evident that at least one member of this family of
molecules, 2-heptyl-3-hydroxy-4-quinolone, has a role in cell-
to-cell signaling. The modern 4-quinolone antibiotics are
halogenated at the 6 or 8 position and are commonly used to
treat a variety of both Gram-positive and Gram-negative
infections (29). These molecules are bactericidal and are
believed to target DNA gyrase, which can be naturally mutated
in P. aeruginosa to produce resistant strains (30, 31). Despite
the development of this resistance phenotype, some 4-quino-
lone antibiotics have a secondary effect in resistant strains. The
synthesis of a number of virulence factors, many of which
(including elastase) are controlled by quorum sensing, is
reduced by 4-quinolone antibiotics (32). This finding is sup-
ported by in vivo studies in which 4-quinolone antibiotic
therapy has been shown to reduce lung damage in rats without
decreasing the bacterial population (33). The mechanisms of
such activities are unknown; however, our results lead us to
theorize that 4-quinolone antibiotics may interfere with
4-quinolone signaling and gene activation. Confirmation of
such a hypothesis would suggest that 4-quinolone signal mol-
ecules may be a viable target for the development of antibac-
terial therapies. It is also interesting to note that many synthetic
4-quinolones are exported by active efflux (reviewed in ref. 34)
and recent reports show that active efflux is involved in the
export of the P. aeruginosa autoinducer 3-oxo-C12-HSL (35,
36). This leads to the speculation that PQS may be exported by
active efflux and that this transport mechanism could be
involved in multiple cell-to-cell signaling pathways.
P. aeruginosa produces a myriad of secondary metabolites,
most of which (including 4-quinolones) were discovered because
they possess an observable bioactivity such as antibacterial or
phytotoxic activity (28). PQS does not have detectable anti-
Staphylococcus aureus or anti-E. coli activity (data not shown).
However, this molecule showed activity as an intercellular signal
that induced the P. aeruginosa virulence gene lasB. These findings
lead to the conclusion that acyl-homoserine lactones represent
one type of cell-to-cell signal in P. aeruginosa but that there are
also other types of intercellular signals involved in the regulation
of virulence gene expression. It has previously been shown that
other Gram-negative bacteria produce quorum sensing signals
that are not acyl-homoserine lactones. Ralstonia solanacearum
has been shown to produce a fatty acid methyl ester that acts as
a signal (37), and both E. coli and Salmonella typhimurium
produce an unidentified intercellular signal that appears to not be
an acyl-homoserine lactone (38). The discovery that 4-quinolones
can act as intercellular signals demonstrates that bacterial cell-
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to-cell signals are an increasingly diverse group of molecules. The
elucidation of the mechanism by which PQS regulates lasB should
be an important first step toward understanding the role of this
type of signaling in P. aeruginosa virulence.
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